View Author
patient cancer study pylori lesion gastriti dysplasia metaplasia helicobacter premalignant biopsy level treatment diagnosis helicobacter pylori infection endoscopy surveillance infection gastroenterology serum follow-up factor pepsinogen group cancer risk hbeag eradication progression endoscopic pylori eradication population gastroenterol result therapy hepatitis table hbeag loss effect stage prevalence signi analysis signi ficantly helicobacter pylori risk factors department leptin incidence development serum leptin levels baseline screening value response netherland fication premalignant lesions cohort 1.0 corpus helicobacter pylori eradication trial carcinoma pylori infection atrophy subject mucosa amantadine grade university system control genotype ribavirin aliment pharmacol classi hepatitis c disease evidence surveillance endoscopy
10 Most Recent Publications
|
Follow-up of premalignant lesions in patients at risk for progression to gastric cancer
(Article)
Hoed, C.M. den Holster, I.L. Capelle, L.G. Vries, R.A. de Hartog, B. den Borg, F. ter Biermann, K. Kuipers, E.J. |
2013-03-29
|
|
Premalignant gastric lesions in patients with gastric mucosa-associated lymphoid tissue lymphoma and metachronous gastric adenocarcinoma: A case-control study
(Article)
Capelle, L.G. Hoed, C.M. den Vries, R.A. de Biermann, K. Casparie, M.K. Meijer, G.A. Kuipers, E.J. |
2012-01-01
|
|
Management of precancerous conditions and lesions in the stomach (MAPS): Guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED)
(Article)
Dinis-Ribeiro, M. Areia, M. Dumonceau, J.M. MacHado, J.C. MacEdo, G. Malfertheiner, P. Matysiak-Budnik, T. Mégraud, F. Miki, K. O'Morain, C. Peek, R.M. Ponchon, T. Vries, R.A. de Ristimaki, A. Rembacken, B. Carneiro, F. Kuipers, E.J. Marcos-Pinto, R. Monteiro-Soares, M. O'Connor, A. Pereira, C.F. Pimentel-Nunes, P. Correia, R. Ensari, A. |
2012-01-01
|
|
Gastric cancer in young patients: Clues on a possible separate entity requiring a watchful approach
(Article)
Vries, R.A. de Kuipers, E.J. |
2011-11-01
|
|
Predictors for neoplastic progression in patients with Barrett's esophagus: A prospective cohort study
(Article)
Sikkema, M. Looman, C.W.N. Giard, R.W.M. Lesterhuis, W. Heinhuis, R. Klinkenberg-Knol, E.C. Meijer, G.A. Borg, F. ter Arends, J.W. Kolkman, J.J. Van Baarlen, J. Vries, R.A. de Steyerberg, E.W. Mulder, A.H. Tilburg, A.J.P. van Offerhaus, G.J. Kate, F.J.W. ten Kusters, J.G. Kuipers, E.J. Siersema, P.D. Kerkhof, M. Kastelein, F. Dekken, H. van Vuuren, A.J. van Bode, W.A. Valk, H. van der Ouwendijk, R.J.T. |
2011-07-01
|
|
Biopsy strategies for endoscopic surveillance of pre-malignant gastric lesions
(Article)
Vries, A.C. de Haringsma, J. Vries, R.A. de Borg, F. ter Grieken, N.C.T. van Meijer, G.A. Dekken, H. van Kuipers, E.J. |
2010-08-01
|
|
No beneficial effects of amantadine in treatment of chronic hepatitis C patients
(Article)
Soest, H. van Schaar, P.J. van der Sluys Veer, A. van der Siersema, P.D. Schipper, M.E.I. Erpecum, K.J. van Boland , G.J. Koek, G.H. Vries, R.A. de Ooteghem, N.A. Hoek, B. van Drenth, J.P.H. Vrolijk, J.M. Lieverse, R.J. Houben, P. |
2010-07-01
|
|
The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis
(Article)
Capelle, L.G. Vries, R.A. de Haringsma, J. Borg, F. ter Bruno, M.J. Dekken, H. van Meijer, J. Grieken, N.C.T. van Kuipers, E.J. |
2010-06-01
|
|
Serum levels of leptin as marker for patients at high risk of gastric cancer
(Article)
Capelle, L.G. Vries, R.A. de Haringsma, J. Steyerberg, E.W. Looman, C.W.N. Nagtzaam, N.M. Dekken, H. van Borg, F. ter Kuipers, E.J. |
2009-12-01
|
|
Response to Rugge et al., Fuccio et al., and de Paoli
(Article)
Vries, R.A. de Kuipers, E.J. Rauws, E.A.J. |
2009-12-01
|
